What does Inhibrx, Inc. do?

Jun 22 2025 07:02 PM IST
share
Share Via
Inhibrx, Inc. is a clinical-stage biotechnology company developing biologic therapeutics for life-threatening conditions, with a market cap of approximately $770 million and a recent net profit of -$79 million. The company has no dividend yield and significant negative return on equity.
Overview:
Inhibrx, Inc. is a clinical-stage biotechnology company focused on developing biologic therapeutics for life-threatening conditions, operating within the small-cap market.

Financial Snapshot:
Most recent Net Profit: -79 Million (Quarterly Results - Mar 2024)
Market cap: USD 770.13 Million (Small Cap)

Key Metrics:
P/E: NA (Loss Making)
Industry P/E: NA
Dividend Yield: 0.00%
Debt Equity: -3.64
Return on Equity: -2,344.01%
Price to Book: 66.57

Contact Details:
Address: 11025 N. Torrey Pines Road, Suite 200, La Jolla CA 92037
Tel: 1 858 7954220
Website: https://inhibrx.com/
{{stockdata.stock.stock_name.value}} Live

{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)

{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)


Our weekly and monthly stock recommendations are here
Loading...
{{!sm.blur ? sm.comp_name : ''}}
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Entry Price
Target Price
{{sm.target_price }} ({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
Is Inhibrx, Inc. overvalued or undervalued?
Jun 25 2025 09:19 AM IST
share
Share Via
Is Inhibrx, Inc. technically bullish or bearish?
Jun 25 2025 09:03 AM IST
share
Share Via
Who are in the management team of Inhibrx, Inc.?
Jun 22 2025 10:43 PM IST
share
Share Via